# Single-arm, Multi-center Study Evaluating the Acceptance and Feasibility of a Digital Remote Monitoring Tool Configured for Patients With ATTR-CM: ACO-Monitor

> **NCT07557147** · — · NOT_YET_RECRUITING · sponsor: **Bayer** · enrollment: 60 (estimated)

## Conditions studied

- Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

## Interventions

- **DEVICE:** Luscii

## Key facts

- **NCT ID:** NCT07557147
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-22
- **Primary completion:** 2027-11-22
- **Final completion:** 2027-12-22
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07557147

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07557147, "Single-arm, Multi-center Study Evaluating the Acceptance and Feasibility of a Digital Remote Monitoring Tool Configured for Patients With ATTR-CM: ACO-Monitor". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07557147. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*